Intrathecal baclofen for progressive neurological disease in childhood: A systematic review of literature

被引:16
作者
Bonouvrie, Laura A. [3 ]
van Schie, Petra E. M. [3 ]
Becher, Jules G. [3 ]
van Ouwerkerk, Willem J. R. [2 ]
Vermeulen, R. Jeroen [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Child Neurol, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Neurosurg, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands
关键词
Intrathecal baclofen; Progressive neurological disease; Spasticity; HEREDITARY SPASTIC PARAPARESIS; CEREBRAL-PALSY; THERAPY; SCOLIOSIS; CHILDREN; GAIT; PARAPLEGIA; MANAGEMENT; BENEFITS; EFFICACY;
D O I
10.1016/j.ejpn.2011.07.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Intrathecal baclofen (ITB) treatment is frequently used for individuals with severe, but non-progressive, spasticity refractory to oral treatment. However, experiences with ITB in patients with progressive neurological disorders of childhood causing spasticity are limited. Aim: To investigate whether ITB is an option in patients with progressive neurological disorders causing spasticity in childhood. Design: A systematic literature search in Embase, Pubmed and the Cochrane Library was performed. Results: We identified six eligible studies considering patients with progressive neurological disease in childhood and receiving ITB treatment. The studies included a total of seven paediatric patients and four adult patients. Improvement was reported in spasticity, spasms, pain, gait, activities of daily life and providing care. High satisfaction is described. Conclusions: ITB has beneficial effects in paediatric patients with progressive neurological disease. However, the level of evidence is limited due to the small number of available studies and due to the poor quality of these studies. (C) 2011 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:279 / 284
页数:6
相关论文
共 27 条
[1]   Intrathecal baclofen for childhood hypertonia [J].
Albright, A. Leland .
CHILDS NERVOUS SYSTEM, 2007, 23 (09) :971-979
[2]  
Albright A Leland, 2006, Neurosurg Focus, V21, pe3
[3]   Best-practice surgical techniques for intrathecal baclofen therapy [J].
Albright, AL ;
Turner, M ;
Pattisapu, JV .
JOURNAL OF NEUROSURGERY, 2006, 104 (04) :233-239
[4]   Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin [J].
Albright, AL ;
Gilmartin, R ;
Swift, D ;
Krach, LE ;
Ivanhoe, CB ;
McLaughlin, JF .
JOURNAL OF NEUROSURGERY, 2003, 98 (02) :291-295
[5]   Intrathecal baclofen in the treatment of painful, disabling spasms in Friedreich's ataxia [J].
Ben Smail, D ;
Jacq, C ;
Denys, P ;
Bussel, B .
MOVEMENT DISORDERS, 2005, 20 (06) :758-759
[6]   'Satisfaction with intrathecal baclofen treatment in paediatric patients with progressive neurological disease' [J].
Bonouvrie, L. A. ;
van Schie, P. E. M. ;
Becher, J. G. ;
van Ouwerkerk, W. J. R. ;
Vermeulen, R. J. .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2008, 50 (08) :636-638
[7]   Intrathecal baclofen in X-linked adrenoleukodystrophy [J].
Chu, MLY ;
Sala, DA ;
Weiner, HL .
PEDIATRIC NEUROLOGY, 2001, 24 (02) :156-158
[8]   Effect of intrathecal baclofen on gait control in human hereditary spastic paraparesis [J].
Dan, B ;
Bouillot, E ;
Bengoetxea, A ;
Cheron, G .
NEUROSCIENCE LETTERS, 2000, 280 (03) :175-178
[9]   Intrathecal baclofen normalizes motor strategy for squatting in familial spastic paraplegia: a case study [J].
Dan, B ;
Cheron, G .
NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY, 2000, 30 (01) :43-48
[10]   Consensus on the appropriate use of intrathecal baclofen (ITB) therapy in paediatric spasticity [J].
Dan, Bernard ;
Motta, Francesco ;
Vles, Johann S. H. ;
Vloeberghs, Michael ;
Becher, Jules G. ;
Eunson, Paul ;
Gautheron, Vincent ;
Luetjen, Sonnhild ;
Mall, Volker ;
Ignacio Pascual-Pascual, Samuel ;
Pauwels, Petra ;
Roste, Geir Ketil .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2010, 14 (01) :19-28